Abstract:Takotsubo syndrome (TTS) is identified as an acute severe ventricular systolic dysfunction, which is usually characterized by reversible and transient akinesia of walls of the ventricle in the absence of a significant obstructive coronary artery disease (CAD). Patients present with chest pain, ST-segment elevation or ischemia signs on ECG and increased troponin, similar to myocardial infarction. Currently, the known mechanisms associated with the development of TTS include elevated levels of circulating plasma catecholamines and their metabolites, coronary microvascular dysfunction, sympathetic hyperexcitability, inflammation, estrogen deficiency, spasm of the epicardial coronary vessels, genetic predisposition and thyroidal dysfunction. However, the real etiologic link remains unclear and seems to be multifactorial. Currently, the elusive pathogenesis of TTS and the lack of optimal treatment leads to the necessity of the application of experimental models or platforms for studying TTS. Excessive catecholamines can cause weakened ventricular wall motion at the apex and increased basal motion due to the apicobasal adrenoceptor gradient. The use of beta-blockers does not seem to impact the outcome of TTS patients, suggesting that signaling other than the beta-adrenoceptor-associated pathway is also involved and that the pathogenesis may be more complex than it was expected. Herein, we review the pathophysiological mechanisms related to TTS; preclinical TTS models and platforms such as animal models, human-induced pluripotent stem cell-derived cardiomyocyte (hiPSC-CM) models and their usefulness for TTS studies, including exploring and improving the understanding of the pathomechanism of the disease. This might be helpful to provide novel insights on the exact pathophysiological mechanisms and may offer more information for experimental and clinical research on TTS.

Left Ventricular Outflow Tract Obstruction/Hypertrophic Cardiomyopathy/Takotsubo Syndrome: A New Hypothesis of Takotsubo Syndrome Pathophysiology

Frequent POCUS and auscultation for an earlier diagnosis of takotsubo syndrome and unraveling of its pathophysiology: the possible crucial role of LVOTO

Takotsubo Syndrome: Translational Implications and Pathomechanisms

Takotsubo Syndrome: Pathophysiology, Emerging Concepts, and Clinical Implications

TakoTsubo Syndrome: A Well-Known Disease but Not Everything Is Clear Yet

The Brain-Heart Connection in Takotsubo Syndrome: The Central Nervous System, Sympathetic Nervous System, and Catecholamine Overload

Epidemiology, Diagnosis, and Treatment of Takotsubo Syndrome: a Comprehensive Review

Epidemiology, pathogenesis, and management of takotsubo syndrome

Acute myocardial infarction complicated with takotsubo syn-drome in an elderly patient: case report and literature review

Takotsubo syndrome complicated by cardiogenic shock due to left ventricular outflow tract obstruction, acute mitral regurgitation, and atrial fibrillation: a case report

Pathophysiology of Takotsubo Syndrome as A Bridge to Personalized Treatment

[Takotsubo cardiomyopathy: current evidence from observational studies and pathophysiological background]

Exploratory Review of the Takotsubo Syndrome and the Possible Role of the Psychosocial Stress Response and Inflammaging

Takotsubo Syndrome: Differences between Peripartum Period and General Population

Thromboembolic Complications in Takotsubo Cardiomyopathy

Clinical perspectives: Takotsubo cardiomyopathy

Association of spontaneous coronary artery dissection and takotsubo syndrome: What has been suspected has been found

Takotsubo Cardiomyopathy in the Absence of an Identifiable Emotional Stressor

A case report of cardiogenic shock from takotsubo cardiomyopathy with left ventricular outflow tract obstruction: fundamental lessons in cardiac pathophysiology

Takotsubo syndrome triggered by emotional and physical stress due to coincidental immobilization resembling the experimental model of the disease - a case report

Is Takotsubo syndrome induced by patent ductus arteriosus occlusion?